-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $95

Benzinga · 01/06/2023 09:22
Morgan Stanley analyst Cecilia Furlong maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $92 to $95.